COAVE TX

At Coave Therapeutics, we are leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative and ocular diseases... Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors... As a result, our ALIGATER technology offers the potential to generate coAAV based gene therapies with improved delivery to target tissue, at lower doses, thus limiting systemic and local toxicity.

Also known as: Coave Therapeutics

Primary location: Paris France